Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0FQRJB
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
HuN901-CC-1065
|
|||||
| Synonyms |
HuN901-CC1065
Click to Show/Hide
|
|||||
| Organization |
ImmunoGen, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Small cell lung cancer [ICD11:2C25]
Clinical candidate
|
|||||
| Antibody Name |
Lorvotuzumab
|
Antibody Info | ||||
| Antigen Name |
Neural cell adhesion molecule 1 (NCAM1)
|
Antigen Info | ||||
| Payload Name |
Rachelmycin
|
Payload Info | ||||
| Therapeutic Target |
Human Deoxyribonucleic acid (hDNA)
|
Target Info | ||||
| Linker Name |
Cleavable disulfide
|
Linker Info | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.